Literature DB >> 31560036

Depression Severity as a Risk Factor of Sarcopenic Obesity in Morbidly Obese Patients.

V Venant1, M Pouget, C Lahaye, E Gentes, B Pereira, C Lambert, J Debarges, C Domingues-Faria, C Palmier-Forestier, N Farigon, M Miolanne, Y Boirie.   

Abstract

SETTING: Etiopathogenic factors of physical disability in obesity are numerous, underestimated and not sought in the non-geriatric population. Amongst these factors, depression may favor the development of sarcopenic obesity by reducing strength and physical performance even in the absence of overt muscle loss. Objectives and participants: To study the link between depression status and muscle functional disorders (dynapenia) in a population of adult subjects with severe and morbid obesity. MEASUREMENTS: Patients were assessed for body composition, grip strength, the Short Physical Performances Battery test (SPPB), for depression according to the Beck II score as well as for metabolic parameters through biological tests.
RESULTS: In 373 obese subjects (mean age 44 ± 13y and BMI 43 ± 6 kg/m²), the prevalence of depression was 53% with 18% having mild depression, 18% moderate depression and 16% severe depression. Depression was significantly related to dynapenia: 62% of dynapenic (D) patients suffered from depression compared to 50% of non-dynapenic (ND) patients (p = 0.036). The Beck questionnaire score for D patients was 20 ± 13 and 15 ± 10 for ND patients (p = 0.001). The depression intensity was significantly correlated with dynapenia with D patients having a higher severe depression degree than ND patients (30% versus 11%; p < 0.0001). Fat-free to fat mass ratio was also significantly correlated with dynapenia (p = 0.01). In multivariate analysis, the presence of depression was twice as likely to be associated with dynapenia.
CONCLUSIONS: Depression is associated with a reduction of muscle function in severe obesity in relation to its severity and to changes in fat to fat-free mass, suggesting that screening and prevention of sarcopenic obesity should be considered in adult obese patients with depression.

Entities:  

Keywords:  Obesity; depression; mobility; muscle; sarcopenia

Mesh:

Year:  2019        PMID: 31560036     DOI: 10.1007/s12603-019-1218-6

Source DB:  PubMed          Journal:  J Nutr Health Aging        ISSN: 1279-7707            Impact factor:   4.075


  31 in total

1.  Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery.

Authors:  J M Guralnik; L Ferrucci; C F Pieper; S G Leveille; K S Markides; G V Ostir; S Studenski; L F Berkman; R B Wallace
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2000-04       Impact factor: 6.053

2.  Prediction of whole-body and segmental body composition by bioelectrical impedance in morbidly obese subjects.

Authors:  Amanda Jiménez; Wilberto Omaña; Lílliam Flores; María José Coves; Diego Bellido; Verónica Perea; Josep Vidal
Journal:  Obes Surg       Date:  2012-04       Impact factor: 4.129

3.  Prevalence of comorbid depression and obesity in general practice.

Authors:  Majo Nikolic
Journal:  Br J Gen Pract       Date:  2015-09       Impact factor: 5.386

4.  Sarcopenic obesity is associated with lower indicators of psychological health and quality of life in Koreans.

Authors:  Yoonsu Cho; So-Youn Shin; Min-Jeong Shin
Journal:  Nutr Res       Date:  2015-04-10       Impact factor: 3.315

Review 5.  Sarcopenic obesity: A Critical appraisal of the current evidence.

Authors:  C M M Prado; J C K Wells; S R Smith; B C M Stephan; M Siervo
Journal:  Clin Nutr       Date:  2012-07-17       Impact factor: 7.324

6.  Dynapenic abdominal obesity as predictor of mortality and disability worsening in older adults: A 10-year prospective study.

Authors:  Andrea P Rossi; Francesco Fantin; Cesare Caliari; Elena Zoico; Gloria Mazzali; Marina Zanardo; Paolo Bertassello; Valeria Zanandrea; Rocco Micciolo; Mauro Zamboni
Journal:  Clin Nutr       Date:  2015-02-19       Impact factor: 7.324

7.  Dimensions of the Beck Depression Inventory-II in clinically depressed outpatients.

Authors:  R A Steer; R Ball; W F Ranieri; A T Beck
Journal:  J Clin Psychol       Date:  1999-01

Review 8.  Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies.

Authors:  Floriana S Luppino; Leonore M de Wit; Paul F Bouvy; Theo Stijnen; Pim Cuijpers; Brenda W J H Penninx; Frans G Zitman
Journal:  Arch Gen Psychiatry       Date:  2010-03

Review 9.  Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives.

Authors:  Y Rolland; S Czerwinski; G Abellan Van Kan; J E Morley; M Cesari; G Onder; J Woo; R Baumgartner; F Pillard; Y Boirie; W M C Chumlea; B Vellas
Journal:  J Nutr Health Aging       Date:  2008 Aug-Sep       Impact factor: 4.075

10.  Sarcopenic obesity and risk of new onset depressive symptoms in older adults: English Longitudinal Study of Ageing.

Authors:  M Hamer; G D Batty; M Kivimaki
Journal:  Int J Obes (Lond)       Date:  2015-06-30       Impact factor: 5.095

View more
  2 in total

Review 1.  Prevalence of depression in patients with sarcopenia and correlation between the two diseases: systematic review and meta-analysis.

Authors:  Zhenzhen Li; Xiang Tong; Yao Ma; Ting Bao; Jirong Yue
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-01-08       Impact factor: 12.063

2.  An association analysis between hypertension, dementia, and depression and the phases of pre-sarcopenia to sarcopenia: A cross-sectional analysis.

Authors:  Takeshi Endo; Kenju Akai; Tsunetaka Kijima; Shigetaka Kitahara; Takafumi Abe; Miwako Takeda; Toru Nabika; Shozo Yano; Minoru Isomura
Journal:  PLoS One       Date:  2021-07-22       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.